Concurrent Investment Advisors LLC Has $3.55 Million Stake in Corteva, Inc. $CTVA

Concurrent Investment Advisors LLC boosted its stake in Corteva, Inc. (NYSE:CTVA) by 16.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 41,872 shares of the company’s stock after acquiring an additional 5,892 shares during the quarter. Concurrent Investment Advisors LLC’s holdings in Corteva were worth $3,546,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the company. EFG International AG bought a new stake in shares of Corteva in the second quarter valued at about $25,000. Compass Financial Management LLC bought a new position in shares of Corteva during the second quarter worth about $25,000. Elevation Wealth Partners LLC raised its position in Corteva by 334.6% in the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after buying an additional 261 shares during the last quarter. Clearstead Trust LLC bought a new stake in Corteva in the 2nd quarter valued at approximately $31,000. Finally, JPL Wealth Management LLC acquired a new position in Corteva during the 3rd quarter worth approximately $25,000. Institutional investors own 81.54% of the company’s stock.

Corteva Trading Down 0.1%

Shares of NYSE:CTVA opened at $87.78 on Tuesday. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $90.97. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. The company has a market capitalization of $58.57 billion, a P/E ratio of 58.13, a price-to-earnings-growth ratio of 2.70 and a beta of 0.57. The company has a 50-day simple moving average of $83.51 and a 200 day simple moving average of $81.13.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. During the same quarter in the previous year, the business earned $2.20 earnings per share. The business’s revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Sell-side analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. Corteva’s payout ratio is presently 47.68%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the stock. Citigroup raised their price target on shares of Corteva from $85.00 to $86.00 and gave the stock a “neutral” rating in a research note on Monday, August 3rd. Royal Bank Of Canada restated an “overweight” rating on shares of Corteva in a report on Friday, August 28th. Oppenheimer raised their target price on shares of Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a research report on Thursday, July 23rd. Mizuho lifted their price target on shares of Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a research note on Tuesday, July 14th. Finally, BMO Capital Markets boosted their price target on shares of Corteva from $95.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, August 3rd. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $91.50.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.